Published in Cancer Epidemiol Biomarkers Prev on October 01, 2004
Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio) | NCT00005260
Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care (2012) 2.21
Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia. Korean J Urol (2014) 1.74
Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Prev Res (Phila) (2010) 1.62
The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J Clin Gastroenterol (2014) 1.57
Metabolic syndrome and urologic diseases. Rev Urol (2010) 1.09
The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence. J Exp Clin Cancer Res (2013) 1.08
Racial differences in risk of prostate cancer associated with metabolic syndrome. Urology (2009) 1.08
Urological aspects of the metabolic syndrome. Nat Rev Urol (2011) 1.06
New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPK. Clin Cancer Res (2010) 1.06
The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study. BJU Int (2010) 1.06
Symposium introduction: metabolic syndrome and the onset of cancer. Am J Clin Nutr (2007) 1.04
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev (2010) 1.02
Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India. Indian J Urol (2011) 0.97
Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study. Crit Rev Oncol Hematol (2008) 0.96
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study. BJU Int (2014) 0.87
Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis (2012) 0.86
Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice. Am J Clin Nutr (2007) 0.86
Prostate cancer in patients with metabolic syndrome is associated with low grade Gleason score when diagnosed on biopsy. Korean J Urol (2012) 0.83
The pathogenesis of prostate cancer: from molecular to metabolic alterations. Diagn Histopathol (Oxf) (2008) 0.81
A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor. Breast Cancer Res Treat (2011) 0.81
Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population. ISRN Oncol (2013) 0.81
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis. Prostate Cancer Prostatic Dis (2015) 0.79
Quality of Life and Sexual Health in the Aging of PCa Survivors. Int J Endocrinol (2014) 0.77
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study. BMC Cancer (2016) 0.76
Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy? Ther Adv Med Oncol (2015) 0.76
Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada. BMC Public Health (2015) 0.76
SIMBOSPROST: Prevalence of metabolic syndrome and osteoporosis in prostate cancer patients treated with radiotherapy and androgen deprivation therapy: A multicentre, cross-sectional study. Rep Pract Oncol Radiother (2015) 0.75
Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis (2017) 0.75
Preoperative erectile function and the pathologic features of prostate cancer. Int Braz J Urol (2015) 0.75
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 7.45
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet (2009) 7.24
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA (2003) 4.01
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med (2004) 3.80
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst (2005) 3.73
Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA (2012) 3.67
Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol (2002) 3.66
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst (2005) 3.07
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care (2004) 3.07
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med (2006) 3.05
Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes (2005) 2.82
Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology (2005) 2.80
Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. Arterioscler Thromb Vasc Biol (2007) 2.74
Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst (2007) 2.70
Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care (2002) 2.69
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol (2002) 2.63
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation (2003) 2.63
Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab (2007) 2.63
Life course socioeconomic conditions and adult psychosocial functioning. Int J Epidemiol (2002) 2.57
Lifestyle intervention for prevention of type 2 diabetes in primary health care: one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care (2010) 2.50
NORDCAN--a Nordic tool for cancer information, planning, quality control and research. Acta Oncol (2010) 2.48
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst (2002) 2.44
Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet (2003) 2.43
The Finnish Cancer Registry as follow-up source of a large trial cohort--accuracy and delay. Acta Oncol (2002) 2.40
Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer (2005) 2.35
Personality traits and cancer risk and survival based on Finnish and Swedish registry data. Am J Epidemiol (2010) 2.30
Cardiorespiratory fitness and the risk for stroke in men. Arch Intern Med (2003) 2.22
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol (2007) 2.17
Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler Thromb Vasc Biol (2004) 2.15
Statins and cancer: A systematic review and meta-analysis. Eur J Cancer (2008) 2.15
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl (2008) 1.97
The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study. Eur Heart J (2004) 1.96
Outcome-dependent sampling: an efficient sampling and inference procedure for studies with a continuous outcome. Epidemiology (2007) 1.92
Socioeconomic position across the lifecourse and cognitive function in late middle age. J Gerontol B Psychol Sci Soc Sci (2002) 1.92
National type 2 diabetes prevention programme in Finland: FIN-D2D. Int J Circumpolar Health (2007) 1.92
Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension (2004) 1.83
Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr (2008) 1.81
Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer (2006) 1.78
Occupational physical activity, energy expenditure and 11-year progression of carotid atherosclerosis. Scand J Work Environ Health (2007) 1.77
Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev (2006) 1.75
Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ Health Perspect (2008) 1.71
Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc (2003) 1.70
Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix. J Clin Oncol (2008) 1.69
Cancer incidence in multiple sclerosis: a 35-year follow-up. Neuroepidemiology (2004) 1.69
Systolic blood pressure during recovery from exercise and the risk of acute myocardial infarction in middle-aged men. Hypertension (2004) 1.67
Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am J Clin Nutr (2007) 1.65
Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med (2005) 1.62
Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control (2007) 1.61
Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol (2006) 1.61
Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries. Occup Environ Med (2014) 1.61
Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60
Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology (2008) 1.59
Dietary fatty acids and cardiovascular disease: an epidemiological approach. Prog Lipid Res (2008) 1.58
The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr (2002) 1.57
Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab (2006) 1.54
A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab (2005) 1.51
Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr (2004) 1.51
Incidence of cancer and statin usage--record linkage study. Int J Cancer (2010) 1.51
Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol (2003) 1.51
FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther (2005) 1.51
Statin usage and all-cause and disease-specific mortality in a nationwide study. Pharmacoepidemiol Drug Saf (2011) 1.50
Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens (2004) 1.49
Perceived health as a predictor of early retirement. Scand J Work Environ Health (2004) 1.48
Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ (2005) 1.47
Effect of intensive counselling on physical activity in pregnant women at high risk for gestational diabetes mellitus. A clinical study in primary care. Prim Care Diabetes (2012) 1.46
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis. Diabetologia (2014) 1.46
[Insulin pump in the treatment of adult age diabetes]. Duodecim (2005) 1.46
Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer (2008) 1.44
Cholangiocarcinoma among workers in the printing industry: using the NOCCA database to elucidate the generalisability of a cluster report from Japan. Occup Environ Med (2013) 1.42
[A certain increase of skin cancer among pilots]. Lakartidningen (2003) 1.41
Risk of second cancer among women with breast cancer. Int J Cancer (2006) 1.41
Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ Health (2010) 1.39
Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol (1985) (2004) 1.39
Left atrium size and the risk of cardiovascular death in middle-aged men. Arch Intern Med (2005) 1.37
Dark chocolate consumption increases HDL cholesterol concentration and chocolate fatty acids may inhibit lipid peroxidation in healthy humans. Free Radic Biol Med (2004) 1.36
Metabolic syndrome in patients with schizophrenia. J Clin Psychiatry (2003) 1.35
Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer (2007) 1.32
Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing. Int J STD AIDS (2006) 1.32
Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study. PLoS One (2008) 1.31
Risk of cancer with metal-on-metal hip replacements: population based study. BMJ (2012) 1.31
Cervical cancer risk factors and feasibility of visual inspection with acetic acid screening in Sudan. Int J Womens Health (2011) 1.26
Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. J Am Coll Cardiol (2008) 1.26
Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes Care (2007) 1.24
Does high sugar consumption exacerbate cardiometabolic risk factors and increase the risk of type 2 diabetes and cardiovascular disease? Food Nutr Res (2012) 1.24